Home> Products> effective urinary health support

{ "products": [ { "_id": "68b0285a8456f6cd1a658352", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ALFUGEM T 5/10", "description": "ALFUGEM T 5/10 is a uniquely formulated combination of Alfuzosin Hydrochloride ER and Tadalafil, created to manage two common male health concerns—benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). This dual-benefit tablet not only helps relieve urinary symptoms caused by an enlarged prostate but also enhances sexual performance by improving blood flow to penile tissues.\n\nAlfuzosin, an alpha-1 adrenergic blocker, works by relaxing the smooth muscles of the prostate and bladder neck, allowing for easier urine flow. On the other hand, Tadalafil, a PDE5 inhibitor, relaxes blood vessels and supports better erections during sexual activity. Together, they offer a holistic treatment option for men dealing with both prostate-related urinary difficulties and sexual health concerns.\n\nUses of ALFUGEM T 5/10\n\nBenign Prostatic Hyperplasia (BPH): Eases urinary issues such as weak stream, frequent urination, incomplete bladder emptying, and difficulty initiating urination.\n\nErectile Dysfunction (ED): Improves erectile quality and sexual satisfaction.\n\nDual Therapy: Provides relief for men suffering from both BPH and ED, minimizing the need for multiple medications.\n\nEnhanced Quality of Life: Restores comfort, confidence, and overall wellness by improving both urinary and sexual functions.\n\nSide Effects of ALFUGEM T 5/10\n\nLike most medications, ALFUGEM T 5/10 may cause side effects, usually mild and temporary as the body adapts to treatment.\n\nCommon side effects include:\n\nHeadache\n\nDizziness or lightheadedness\n\nNasal congestion\n\nBack pain\n\nFlushing\n\nLess common but serious side effects:\n\nSudden low blood pressure (hypotension)\n\nSevere dizziness or fainting\n\nProlonged, painful erections (priapism – requires urgent care)\n\nVision or hearing disturbances\n\nAllergic reactions (rash, itching, facial/lip/throat swelling)\n\nPrecautions Before Use\n\nHeart Problems: Patients with recent heart attack, stroke, or serious heart disease should only use under strict medical advice.\n\nBlood Pressure: May lower blood pressure—avoid combining with other strong antihypertensives unless prescribed.\n\nNitrate Warning: Must not be used with nitrate medications (for chest pain/angina) due to risk of severe hypotension.\n\nLiver or Kidney Impairment: Dose adjustments may be needed.\n\nAlertness: Can cause dizziness—avoid driving or operating heavy machinery until you know your body’s response.\n\nDrug Interactions\n\nALFUGEM T 5/10 may interact with other medicines:\n\nNitrates (Nitroglycerin, Isosorbide): Can lead to life-threatening hypotension.\n\nAntihypertensives: May intensify blood pressure-lowering effects.\n\nOther PDE5 inhibitors (Sildenafil, Vardenafil): Should not be combined.\n\nStrong CYP3A4 inhibitors (e.g., Ketoconazole, Ritonavir): May increase Alfuzosin or Tadalafil levels.\n\nAlcohol: Increases dizziness and risk of low blood pressure.\n\nConclusion\n\nALFUGEM T 5/10 (Alfuzosin Hydrochloride ER & Tadalafil Tablets) is a comprehensive dual-action therapy designed for men experiencing both urinary issues due to BPH and sexual challenges related to ED. By combining an effective alpha-blocker with a proven PDE5 inhibitor, it provides relief from urinary discomfort while restoring erectile performance and confidence.\n\nWith proper medical guidance, ALFUGEM T 5/10 can greatly improve overall quality of life, making it a reliable option for men seeking urological and sexual wellness in a single solution.", "price": 385.0, "discountamount": 115.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2167, "imageuri": "https://productimages.withfloats.com/actual/68b0285da77b30c98906ef23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b0285da77b30c98906ef23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:58:50.008Z", "updatedon": "2025-08-28T09:58:50.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/alfugem-t-5-10/2167", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Alfuzosin Hydrochloride ER & Tadalafil Tablets", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6810aa8d5a26e4010ea41a99", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH MET", "description": "EMPATECH MET 12.5/500 is a powerful oral antidiabetic combination therapy containing Empagliflozin and Metformin Hydrochloride, designed to manage Type 2 Diabetes Mellitus effectively. This dual-action formula helps control blood sugar levels, supports weight management, and offers added cardiovascular benefits. EMPATECH MET 12.5/500 is particularly beneficial for adults who require a second-line treatment when diet, exercise, and monotherapy are not sufficient.\n\nKey Ingredients\nEmpagliflozin (12.5 mg):\nA sodium-glucose co-transporter-2 (SGLT2) inhibitor that helps reduce blood glucose levels by promoting glucose excretion through urine.\n\nMetformin Hydrochloride (500 mg):\nA biguanide class medication that lowers blood glucose by improving insulin sensitivity and reducing glucose production in the liver.\n\nKey Benefits\nHelps in lowering and maintaining stable blood glucose levels\n\nPromotes weight loss and reduces visceral fat\n\nReduces the risk of cardiovascular complications in diabetic patients\n\nSupports renal protection in people with diabetes and mild kidney dysfunction\n\nOffers a low risk of hypoglycemia compared to some other therapies\n\nImproves glycemic control with a dual mechanism of action\n\nHow Does It Work?\nEMPATECH MET 12.5/500 functions through two complementary mechanisms:\n\nEmpagliflozin works by blocking SGLT2 proteins in the kidneys, reducing the reabsorption of glucose and increasing its excretion via urine. This lowers blood sugar levels independently of insulin action.\n\nMetformin acts primarily by inhibiting hepatic glucose production and improving the body’s sensitivity to insulin, allowing for better uptake and usage of glucose by muscles and fat tissues.\n\nTogether, they provide a comprehensive glycemic control strategy, especially for patients not responding well to monotherapy.\n\nDirections for Use\nTake the tablet as prescribed by your doctor, usually once or twice daily with meals.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nContinue following a healthy diet and regular exercise routine for optimal results.\n\nMonitor blood sugar levels regularly and report any unusual changes to your healthcare provider.\n\nDo not stop the medication without medical advice, even if your blood sugar levels improve.\n\nSide Effects\nCommon Side Effects:\n\nIncreased urination\n\nThirst or dry mouth\n\nNausea or mild gastrointestinal upset\n\nHeadache\n\nFatigue\n\nLess Common but Serious Side Effects:\n\nRisk of urinary tract infections or genital infections\n\nLactic acidosis (rare but serious; associated with Metformin)\n\nDehydration or low blood pressure, especially in elderly patients\n\nElectrolyte imbalances\n\nSeek immediate medical help if you experience severe abdominal pain, muscle cramping, breathing difficulties, or unusual tiredness.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "unusual tiredness", "medical advice", "monotherapy directions", "healthcare provider", "healthy diet", "chew continue", "meals swallow", "fat tissues", "dual mechanism", "hypoglycemia compared", "cardiovascular complications", "secondline treatment", "metformin dehydration", "insulin allowing", "bodys sensitivity", "kidneys reducing", "low risk", "diet exercise", "improving insulin sensitivity", "promoting glucose excretion", "reducing glucose production", "side effects risk", "biguanide class medication", "lowers blood glucose", "low blood pressure", "regular exercise routine", "metformin hydrochloride designed", "urinary tract infections", "dry mouth nausea", "blocking sglt2 proteins" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2093, "imageuri": "https://productimages.withfloats.com/actual/6810aa8f5c4a4ba3d41a8c35.png", "tileimageuri": "https://productimages.withfloats.com/tile/6810aa8f5c4a4ba3d41a8c35.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-29T10:31:41.504Z", "updatedon": "2025-04-29T10:32:46.171Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-met/2093", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin (12.5mg) ,Metformin Hydrochloride (500mg)", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg price", "empagliflozin 12.5 mg+metformin 1000 mg", "empagliflozin 12.5mg brands in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e692a09d2d81bbce938da", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "HEALTHAMAZ HUNGER SYRUP ", "description": "HEALTHAMAZ HUNGER SYRUP \nCyproheptadine Hcl (2mg), Tricholine Citrate (275mg) & Sorbitol (2mg)Syrup\nIntroduction\nHEALTHAMAZ HUNGER SYRUP is a therapeutic syrup designed to stimulate appetite and aid in nutritional intake. This syrup contains a combination of Cyproheptadine Hcl (2mg), Tricholine Citrate (275mg), and Sorbitol (2mg). It is formulated to help individuals who struggle with poor appetite and need additional support to maintain a healthy nutritional status.\n\nComposition\n\nCyproheptadine Hcl (2mg): An antihistamine with appetite-stimulating properties. It works by antagonizing the action of histamine and serotonin in the body, which can increase appetite.\nTricholine Citrate (275mg): A bile acid binding agent that aids in liver function and lipid metabolism, contributing to overall digestive health.\nSorbitol (2mg): A sugar alcohol that acts as an osmotic laxative, aiding in bowel movements and improving digestive health.\nMechanism of Action\n\nCyproheptadine Hcl: Functions by blocking histamine and serotonin receptors, leading to increased appetite and reduced allergic reactions. It is particularly effective in stimulating hunger in individuals with decreased appetite due to medical conditions or treatments.\nTricholine Citrate: Helps in the emulsification of fats, enhancing digestion and absorption of dietary fats. It also supports liver function by promoting bile flow and reducing fat accumulation in the liver.\nSorbitol: Acts as a gentle laxative by drawing water into the bowel, which helps alleviate constipation and improve overall digestive function.\nIndications\nHEALTHAMAZ HUNGER SYRUP is indicated for:\n\nStimulating appetite in individuals with decreased hunger\nSupporting nutritional intake in underweight individuals\nImproving digestion and liver function\nAlleviating mild to moderate constipation\nDosage and Administration\n\nAdults: The typical dosage is 10 ml taken two to three times daily before meals.\nChildren: Dosage should be determined by a pediatrician based on age and weight.\nIt is important to follow the prescribed dosage and not exceed the recommended amount.\nSide Effects\nCommon side effects may include:\n\nDrowsiness or sedation\nDizziness\nDry mouth\nMild gastrointestinal disturbances (nausea, diarrhea)\nAllergic reactions (rash, itching)\nPrecautions\n\nAllergy: Individuals with a known allergy to any component of the syrup should avoid using it.\nPregnancy and Lactation: Consult with a healthcare provider before using this syrup during pregnancy or while breastfeeding.\nChronic Conditions: Patients with chronic conditions such as glaucoma, peptic ulcer, or urinary retention should use this medication with caution and under medical supervision.\nDrug Interactions\n\nCNS Depressants: Concurrent use with other central nervous system depressants (e.g., sedatives, tranquilizers) may enhance sedative effects.\nMAO Inhibitors: Avoid using with monoamine oxidase inhibitors as it may increase the risk of severe side effects.\nAntihypertensive Drugs: Can potentiate the effect of antihypertensive medications, leading to enhanced hypotensive effects.\nConclusion\nHEALTHAMAZ HUNGER SYRUP is an effective solution for stimulating appetite and improving nutritional intake. With its combination of Cyproheptadine Hcl, Tricholine Citrate, and Sorbitol, it offers a multifaceted approach to addressing poor appetite and digestive health. It is crucial to use this syrup as directed by a healthcare professional to ensure safety and efficacy. Always consult with a healthcare provider before starting any new medication, especially if there are underlying health conditions or concurrent medication use.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 145.5, "discountamount": 43.65, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "10 ml", "mild to", "Dry mouth", "bile flow", "dietary fats", "peptic ulcer", "Sorbitol (2mg", "poor appetite", "sugar alcohol", "typical dosage", "new medication", "liver function", "MAO Inhibitors", "Concurrent use", "bowel movements", "gentle laxative", "CNS Depressants", "fat accumulation", "osmotic laxative", "lipid metabolism", "sedative effects", "Drug Interactions", "urinary retention", "therapeutic syrup", "effective solution", "recommended amount", "allergic reactions", "additional support", "Tricholine Citrate", "Cyproheptadine Hcl", "Chronic Conditions", "medical conditions", "serotonin receptors", "medical supervision", "healthcare provider", "hypotensive effects", "severe side effects", "Common side effects", "moderate constipation", "multifaceted approach", "Antihypertensive Drugs", "healthcare professional", "HEALTHAMAZ HUNGER SYRUP", "bile acid binding agent", "overall digestive health", "concurrent medication use", "overall digestive function", "healthy nutritional status", "antihypertensive medications", "underlying health conditions", "monoamine oxidase inhibitors", "Supporting nutritional intake", "appetite-stimulating properties", "underweight individuals Improving", "Mild gastrointestinal disturbances", "other central nervous system depressants" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1929, "imageuri": "https://productimages.withfloats.com/actual/683170bd1b36385fc2426eec.png", "tileimageuri": "https://productimages.withfloats.com/tile/683170bd1b36385fc2426eec.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T10:57:46.274Z", "updatedon": "2025-05-24T07:09:46.555Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/healthamaz-hunger-syrup-/1929", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cyproheptadine Hcl (2mg), Tricholine Citrate (275mg) & Sorbitol (2mg)Syrup", "category": "GENERAL RANGE", "tags": [ "Cyproheptadine Hydrochloride Tricholine Citrate Sy", "Cyproheptadine Hydrochloride Tricholine Citrate & ", "Cyproheptadine HCL Tricholine Citrate and Sorbitol", "Cyproheptadine HCL Tricholine Citrate Sorbitol Syr", "Cyproheptadine Hydrochloride and Tricholine Citrat", "", "Cyproheptadine Hydrochloride and Tricholine Citrat", "", "Cyproheptadine hydrochloride Tricholine Citrate sy" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0baed91d281c30c72ddb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 5/ 1000 ", "description": "GLIDAPAFLOZIN M 5/ 1000 \nDapagliflozin (5mg), Metformin (1000mg)\nIntroduction\nGLIDAPAFLOZIN M 5/1000 is a combination medication designed to provide balanced and effective control over Type 2 diabetes. It combines Dapagliflozin (5 mg) and Metformin (1000 mg), offering a synergistic approach to managing blood glucose levels and supporting overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (5 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (1000 mg): Metformin is a widely used medication for Type 2 diabetes, improving insulin sensitivity, reducing liver glucose production, and decreasing intestinal glucose absorption. It helps lower blood sugar levels and may also support weight management.\nBenefits\nGLIDAPAFLOZIN M 5/1000 offers several advantages for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin, it provides a balanced approach to blood glucose control and metabolic parameters. This combination can lead to improved glycemic control, weight management, and cardiovascular health.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal to minimize gastrointestinal side effects. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 5/1000 should be taken in the morning to maximize its effectiveness throughout the day. It is important to follow the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 5/1000 may include urinary tract infections, genital infections, gastrointestinal disturbances (such as nausea or diarrhea), and potential vitamin B12 deficiency with long-term use. Patients should be aware of these potential side effects and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 5/1000 offers a balanced and effective treatment option for individuals with Type 2 diabetes, combining the benefits of Dapagliflozin and Metformin in a single tablet. Its dual-action mechanism targets multiple aspects of diabetes management, supporting improved glycemic control and metabolic health. Patients should consult their healthcare provider for personalized advice on dosage, monitoring, and management of potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-5-1000-133426", "price": 140.0, "discountamount": 42.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "dose", "meal", "Order", "EMAIL", "nausea", "kidneys", "1000 mg", "morning", "diarrhea", "improved", "concerns", "Patients", "increased", "Metformin", "one tablet", "Conclusion", "monitoring", "weight loss", "information", "individuals", "Introduction", "sterisonline", "tolerability", "sterispharma", "effectiveness", "long-term use", "single tablet", "Dapagliflozin", "CALL/WHATSAPP", "Type 2 diabetes", "dosing schedule", "SGLT2 inhibitor", "GLIDAPAFLOZIN M", "glycemic control", "multiple aspects", "balanced approach", "weight management", "effective control", "blood sugar levels", "several advantages", "Dosage adjustments", "genital infections", "diabetes management", "Common side effects", "personalized advice", "healthcare provider", "individual response", "insulin sensitivity", "synergistic approach", "glucose reabsorption", "metabolic parameters", "blood glucose control", "dual-action mechanism", "cardiovascular health", "Administration Dosage", "combination medication", "potential side effects", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "liver glucose production", "urinary glucose excretion", "effective treatment option", "lower blood glucose levels", "gastrointestinal side effects", "intestinal glucose absorption", "gastrointestinal disturbances", "potential vitamin B12 deficiency" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1318, "imageuri": "https://productimages.withfloats.com/actual/665f0bb10c19ea48b943ceaf.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f0bb10c19ea48b943ceaf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:42:22.464Z", "updatedon": "2024-06-04T12:42:22.464Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-m-5-1000-/1318", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 5/ 1000 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0a9787f0960e14a296d5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 10/1000 ", "description": "GLIDAPAFLOZIN M 10/1000 \nDapagliflozin (10mg), Metformin (1000mg)\nIntroduction\nGLIDAPAFLOZIN M 10/1000 is a potent combination medication designed to effectively manage Type 2 diabetes. It combines Dapagliflozin (10 mg) and Metformin (1000 mg), providing a dual-action approach to blood glucose control and overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (1000 mg): Metformin is a cornerstone medication for Type 2 diabetes, improving insulin sensitivity, reducing liver glucose production, and decreasing intestinal glucose absorption. It helps lower blood sugar levels and may also support weight management.\nBenefits\nGLIDAPAFLOZIN M 10/1000 offers several advantages for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin at higher doses, it provides comprehensive control over blood glucose levels and metabolic parameters. This combination can lead to improved glycemic control, weight management, and cardiovascular health.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal to minimize gastrointestinal side effects. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 10/1000 should be taken in the morning to maximize its effectiveness throughout the day. It is important to adhere to the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 10/1000 may include urinary tract infections, genital infections, gastrointestinal disturbances (such as nausea or diarrhea), and potential vitamin B12 deficiency with long-term use. Patients should be aware of these potential side effects and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 10/1000 provides a comprehensive and effective treatment option for individuals with Type 2 diabetes, combining the benefits of Dapagliflozin and Metformin in a single tablet. Its dual-action mechanism targets multiple aspects of diabetes management, supporting improved glycemic control and metabolic health. Patients should consult their healthcare provider for personalized advice on dosage, monitoring, and management of potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-10-1000-133425", "price": 205.0, "discountamount": 61.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "meal", "lower", "EMAIL", "Order", "nausea", "kidneys", "morning", "1000 mg", "diarrhea", "concerns", "improved", "Patients", "Metformin", "Conclusion", "monitoring", "one tablet", "weight loss", "information", "individuals", "higher doses", "Introduction", "sterisonline", "tolerability", "sterispharma", "effectiveness", "Dapagliflozin", "CALL/WHATSAPP", "long-term use", "single tablet", "SGLT2 inhibitor", "GLIDAPAFLOZIN M", "dosing schedule", "Type 2 diabetes", "multiple aspects", "glycemic control", "weight management", "genital infections", "blood sugar levels", "Dosage adjustments", "several advantages", "Common side effects", "healthcare provider", "insulin sensitivity", "personalized advice", "individual response", "diabetes management", "glucose reabsorption", "dual-action approach", "metabolic parameters", "blood glucose levels", "dual-action mechanism", "cardiovascular health", "comprehensive control", "Administration Dosage", "blood glucose control", "cornerstone medication", "potential side effects", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "liver glucose production", "urinary glucose excretion", "effective treatment option", "gastrointestinal side effects", "potent combination medication", "gastrointestinal disturbances", "intestinal glucose absorption", "potential vitamin B12 deficiency" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1317, "imageuri": "https://productimages.withfloats.com/actual/665f0a99c06ee12d88cb43d9.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f0a99c06ee12d88cb43d9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:37:43.401Z", "updatedon": "2024-06-04T12:37:43.401Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-m-10-1000-/1317", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 10/1000 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f09d8db9fdd21801ec775", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 10/500 ", "description": "GLIDAPAFLOZIN M 10/500 \nDapagliflozin (10mg), Metformin (500mg) SR\nIntroduction\nGLIDAPAFLOZIN M 10/500 combines two potent medications, Dapagliflozin (10 mg) and Metformin (500 mg, sustained-release), into a single tablet. This formulation offers a comprehensive approach to managing Type 2 diabetes by targeting both blood glucose levels and metabolic health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (500 mg, sustained-release): Metformin is a widely used medication that improves insulin sensitivity, reduces glucose production in the liver, and decreases intestinal glucose absorption. The sustained-release formulation ensures a gradual release of Metformin, minimizing gastrointestinal side effects.\nBenefits\nGLIDAPAFLOZIN M 10/500 offers several benefits for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin, it provides dual-action control over blood glucose levels, enhances insulin sensitivity, and supports overall metabolic health. This combination can lead to improved glycemic control and may also assist in weight management.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 10/500 should be taken in the morning to maximize its effectiveness throughout the day. It is important to follow the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 10/500 may include urinary tract infections, genital infections, and gastrointestinal disturbances such as nausea or diarrhea. These side effects are generally mild and transient, but patients should be aware of them and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 10/500 is a convenient and effective option for individuals with Type 2 diabetes, offering dual-action control over blood glucose levels and metabolic health. Its combination of Dapagliflozin and Metformin provides a comprehensive approach to diabetes management, potentially leading to improved outcomes and better quality of life. Patients should consult their healthcare provider for personalized advice on dosage and monitoring.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-10-500-133423", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SR", "day", "meal", "dose", "life", "liver", "Order", "EMAIL", "lower", "better", "500 mg", "nausea", "quality", "kidneys", "morning", "diarrhea", "concerns", "patients", "Metformin", "Mechanism", "increased", "Conclusion", "one tablet", "convenient", "monitoring", "weight loss", "combination", "information", "individuals", "Introduction", "sterisonline", "tolerability", "sterispharma", "Dapagliflozin", "single tablet", "CALL/WHATSAPP", "effectiveness", "GLIDAPAFLOZIN M", "dosing schedule", "gradual release", "SGLT2 inhibitor", "Type 2 diabetes", "several benefits", "effective option", "glycemic control", "weight management", "improved outcomes", "Dosage adjustments", "genital infections", "glucose production", "personalized advice", "diabetes management", "healthcare provider", "individual response", "dual-action control", "insulin sensitivity", "Common side effects", "blood glucose levels", "glucose reabsorption", "Administration Dosage", "two potent medications", "comprehensive approach", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "urinary glucose excretion", "gastrointestinal side effects", "intestinal glucose absorption", "gastrointestinal disturbances", "sustained-release formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1315, "imageuri": "https://productimages.withfloats.com/actual/665f09da137212f68f05951a.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f09da137212f68f05951a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:34:32.323Z", "updatedon": "2024-06-04T12:34:32.323Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glidapaflozin-m-10-500-/1315", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 10/500 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f08f9d91d281c30c72c8a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN 5 ", "description": "GLIDAPAFLOZIN 5 \nDapagliflozin (5mg)\nIntroduction\nGLIDAPAFLOZIN 5 is a targeted medication designed to assist in the management of Type 2 diabetes. It contains 5 mg of Dapagliflozin, an SGLT2 inhibitor renowned for its efficacy in controlling blood glucose levels and supporting overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (5 mg): Dapagliflozin works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys. By doing so, it reduces the reabsorption of glucose into the bloodstream, leading to increased glucose excretion through urine. This mechanism not only helps lower blood sugar levels but also contributes to weight management and may have cardiovascular benefits.\nBenefits\nGLIDAPAFLOZIN 5 offers several advantages for individuals with Type 2 diabetes. Its primary benefit lies in its ability to effectively lower blood glucose levels, which is crucial for diabetes management. Additionally, it may help in reducing body weight and blood pressure, making it a comprehensive treatment option.\n\nDosage and Administration\n\nDosage: The recommended dose is one 5 mg tablet per day. Dosage adjustments may be necessary based on individual response and tolerability, as advised by a healthcare professional.\nAdministration: GLIDAPAFLOZIN 5 should be taken in the morning, with or without food. It is important to maintain a consistent dosing schedule for optimal blood sugar control.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN 5 include urinary tract and genital infections due to increased glucose in the urine. Patients may also experience dehydration-related symptoms such as increased thirst and dry mouth. Monitoring for these side effects is important for overall health management.\n\nConclusion\nGLIDAPAFLOZIN 5 is an effective and targeted medication for individuals with Type 2 diabetes, providing a focused approach to blood sugar control. Its mechanism of action and potential benefits in weight and blood pressure management make it a valuable addition to diabetes treatment plans. Patients should work closely with their healthcare provider to determine the appropriate dosage and monitor for any potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-5-133428", "price": 165.0, "discountamount": 49.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "dose", "food", "urine", "EMAIL", "Order", "Action", "thirst", "morning", "ability", "kidneys", "efficacy", "Patients", "Mechanism", "effective", "dry mouth", "Monitoring", "Conclusion", "body weight", "information", "individuals", "bloodstream", "reabsorption", "sterispharma", "Introduction", "sterisonline", "Dapagliflozin", "GLIDAPAFLOZIN", "CALL/WHATSAPP", "urinary tract", "primary benefit", "SGLT2 inhibitor", "Type 2 diabetes", "one 5 mg tablet", "focused approach", "valuable addition", "weight management", "glucose excretion", "Dosage adjustments", "appropriate dosage", "blood sugar levels", "genital infections", "several advantages", "potential benefits", "diabetes management", "healthcare provider", "individual response", "Common side effects", "targeted medication", "blood glucose levels", "Administration Dosage", "potential side effects", "cardiovascular benefits", "healthcare professional", "diabetes treatment plans", "overall metabolic health", "overall health management", "blood pressure management", "consistent dosing schedule", "optimal blood sugar control", "sodium-glucose cotransporter", "dehydration-related symptoms", "comprehensive treatment option" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1313, "imageuri": "https://productimages.withfloats.com/actual/665f08fac40ee9be01963b03.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f08fac40ee9be01963b03.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:30:49.993Z", "updatedon": "2024-06-04T12:30:49.993Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-5-/1313", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN 5 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f081d8da3a81d5c69e8ec", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN 10 ", "description": "GLIDAPAFLOZIN 10 \nDapagliflozin (10mg)\nIntroduction\nGLIDAPAFLOZIN 10 is a highly effective medication formulated specifically for the treatment of Type 2 diabetes. This oral tablet contains 10 mg of Dapagliflozin, an SGLT2 inhibitor that plays a crucial role in managing blood glucose levels and supporting overall cardiovascular health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin operates by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys. This inhibition prevents the reabsorption of glucose back into the bloodstream, promoting the excretion of glucose through urine. This process not only helps lower blood sugar levels but also aids in calorie reduction and weight management.\nBenefits\nGLIDAPAFLOZIN 10 is particularly beneficial for patients looking to control their blood sugar levels effectively while also addressing other metabolic aspects like weight and blood pressure. It has been associated with cardiovascular benefits, making it a preferred choice for diabetic patients with heart-related concerns.\n\nDosage and Administration\n\nDosage: The recommended starting dose is one 10 mg tablet per day. Dosage adjustments should be based on individual efficacy and tolerability, under the guidance of a healthcare professional.\nAdministration: GLIDAPAFLOZIN 10 should be taken in the morning, with or without food. Consistency in taking the medication at the same time each day is important for maintaining stable glucose levels.\nSide Effects\nThe most common side effects of GLIDAPAFLOZIN 10 include genital and urinary tract infections due to the increased glucose in the urine. Patients may also experience signs of dehydration and low blood pressure. It is important for users to stay well-hydrated and monitor for signs of excessive urination and thirst.\n\nConclusion\nGLIDAPAFLOZIN 10 offers an effective, focused approach to managing Type 2 diabetes through its unique action on renal glucose processing. It simplifies diabetes management by providing a once-daily oral treatment that supports blood sugar control while potentially improving cardiovascular and metabolic health. As with any medication, it is crucial to consult a healthcare provider to tailor the treatment to individual needs and circumstances.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-10-133427\n\n\n\n\n\n", "price": 240.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "Order", "signs", "users", "EMAIL", "urine", "thirst", "choice", "kidneys", "genital", "morning", "guidance", "same time", "Mechanism", "excretion", "Conclusion", "inhibition", "Consistency", "oral tablet", "dehydration", "information", "bloodstream", "Introduction", "reabsorption", "crucial role", "sterispharma", "tolerability", "sterisonline", "GLIDAPAFLOZIN", "circumstances", "CALL/WHATSAPP", "Dapagliflozin", "unique action", "starting dose", "oral treatment", "Type 2 diabetes", "SGLT2 inhibitor", "one 10 mg tablet", "metabolic health", "individual needs", "weight management", "diabetic patients", "calorie reduction", "blood sugar levels", "Dosage adjustments", "low blood pressure", "individual efficacy", "common side effects", "excessive urination", "diabetes management", "healthcare provider", "blood sugar control", "effective medication", "blood glucose levels", "stable glucose levels", "Administration Dosage", "heart-related concerns", "cardiovascular benefits", "healthcare professional", "other metabolic aspects", "urinary tract infections", "renal glucose processing", "effective, focused approach", "sodium-glucose cotransporter", "overall cardiovascular health" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1310, "imageuri": "https://productimages.withfloats.com/actual/665f0820c40ee9be019637c3.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/665f0820c40ee9be019637c3.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:27:09.955Z", "updatedon": "2024-06-04T12:27:09.955Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-10-/1310", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN 10 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665eff188da3a81d5c69e749", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA 3D 10/100/1000 SR ", "description": "GLIDAPA 3D 10/100/1000 SR \nDapaflozin 10, Sitagliptin 100 mg & Metformin SR 1000 mg\nIntroduction\nGLIDAPA 3D 10/100/1000 SR is a comprehensive oral medication tailored for the treatment of Type 2 diabetes. This potent combination incorporates Dapagliflozin (10 mg), Sitagliptin (100 mg), and a higher dose of Metformin (1000 mg, sustained release), designed to effectively manage high blood sugar levels throughout the day.\n\nMechanism of Action\n\nDapagliflozin (10 mg): As an SGLT2 inhibitor, Dapagliflozin facilitates the removal of excess glucose from the body via the urine, helping to reduce blood glucose levels and also supporting weight loss and cardiovascular health.\nSitagliptin (100 mg): A DPP-4 inhibitor, Sitagliptin increases the levels of incretin hormones, which enhances the pancreatic response to high blood sugar after meals by increasing insulin production and decreasing glucagon secretion.\nMetformin SR (1000 mg): The higher dose of Metformin in this formulation works to decrease hepatic glucose production, improve insulin sensitivity, and reduce glucose absorption in the intestines. The sustained-release form minimizes gastrointestinal side effects and provides more stable blood sugar control.\nBenefits\nGLIDAPA 3D 10/100/1000 SR offers a potent therapeutic strategy by combining three drugs, each targeting a different aspect of diabetes management. This not only maximizes glucose control but also simplifies the treatment regimen, potentially enhancing patient compliance and reducing the risk of long-term complications.\n\nDosage and Administration\n\nDosage: The dosage should be tailored to the individual’s current health status, effectiveness of the treatment, and tolerability. Regular monitoring of blood glucose and adjustment of the dose may be necessary.\nAdministration: It is recommended to take the medication once daily in the morning, with or without food. The tablet should be swallowed whole to ensure proper release of Metformin over time.\nSide Effects\nCommon side effects may include urinary tract infections (due to Dapagliflozin), potential gastrointestinal disturbances such as nausea or diarrhea (common with Metformin), and a sore throat or nasopharyngitis associated with Sitagliptin. These side effects are generally mild and manageable.\n\nConclusion\nGLIDAPA 3D 10/100/1000 SR is a highly effective option for managing Type 2 diabetes, offering a strategic blend of three medications to control blood sugar levels, improve metabolic health, and reduce the risk of diabetes-related complications. This enhanced formulation is suitable for patients requiring a robust approach to diabetes management, emphasizing the importance of ongoing collaboration with healthcare providers to tailor and optimize treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-3d-10-100-1000-sr-134216\n\n\n\n\n\n", "price": 595.0, "discountamount": 178.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "time", "food", "body", "risk", "meals", "Order", "EMAIL", "urine", "nausea", "tablet", "Action", "morning", "1000 mg", "removal", "patients", "Benefits", "diarrhea", "Mechanism", "Conclusion", "Dapaflozin", "intestines", "adjustment", "importance", "individual", "weight loss", "Sitagliptin", "higher dose", "three drugs", "information", "sore throat", "tolerability", "Introduction", "sterisonline", "sterispharma", "Metformin SR", "Dapagliflozin", "CALL/WHATSAPP", "effectiveness", "proper release", "excess glucose", "SGLT2 inhibitor", "Type 2 diabetes", "robust approach", "DPP-4 inhibitor", "strategic blend", "nasopharyngitis", "glucose control", "metabolic health", "different aspect", "effective option", "sustained release", "treatment regimen", "incretin hormones", "three medications", "glucagon secretion", "Regular monitoring", "patient compliance", "glucose absorption", "insulin production", "potent combination", "pancreatic response", "diabetes management", "insulin sensitivity", "Common side effects", "enhanced formulation", "healthcare providers", "blood glucose levels", "ongoing collaboration", "cardiovascular health", "Administration Dosage", "current health status", "sustained-release form", "high blood sugar levels", "long-term complications", "urinary tract infections", "GLIDAPA 3D 10/100/1000 SR", "stable blood sugar control", "hepatic glucose production", "potent therapeutic strategy", "gastrointestinal side effects", "comprehensive oral medication", "diabetes-related complications", "potential gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1303, "imageuri": "https://productimages.withfloats.com/actual/665eff1a8e77bb2c7151ebf4.png", "tileimageuri": "https://productimages.withfloats.com/tile/665eff1a8e77bb2c7151ebf4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:48:40.052Z", "updatedon": "2024-06-04T11:48:40.052Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-3d-10-100-1000-sr-/1303", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA 3D 10/100/1000 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }